For years, women fled this treatment - now the turning point has arrived

An article in Ma'ariv reexamines the global panic surrounding hormone therapy following the 2002 WHI study, arguing that new research shows potential benefits for women who have undergone hysterectomy.

An article in Ma'ariv reexamines the global panic surrounding hormone therapy for menopausal women, following the 2002 WHI study. The author, Eli Leon, argues that the original study suffered from methodological issues: the average participant age was 63, significantly older than the age at which women typically begin treatment, and the researchers emphasized a 26% relative risk increase in breast cancer while the absolute risk was only eight additional women per 10,000 per year. Follow-up studies from 2003–2004 led the FDA to issue severe warnings. However, new studies from Stanford University and the UK show that for women who have undergone hysterectomy and receive estrogen alone, the treatment actually reduces the risk of Alzheimer's and dementia. The article does not mention the names of the researchers or the sample sizes of the new studies.